Examkin

Soru

Zorluk: ZorPreventive Care and Screening

During a comprehensive health evaluation, a 38-year-old female patient inquires about her cancer risk. She currently feels well and has no physical complaints. Her medical history includes well-controlled asthma, for which she uses an albuterol inhaler as needed. She exercises regularly and follows a balanced diet.

Upon reviewing her family pedigree, the physician notes that her father was diagnosed with breast cancer at age 55, and her paternal grandmother died from ovarian cancer at age 62. Her mother and two younger sisters are alive and healthy. The patient has one child, whom she breastfed for 6 months. A thorough physical examination today, including a detailed clinical breast examination, reveals no palpable masses, skin changes, or axillary lymphadenopathy.

Based on current preventive care guidelines, which of the following is the most appropriate next step in management regarding this patient's cancer risk?

  1. Referral for formal genetic counseling and consideration of BRCA mutation testingCevap
  2. B
    Initiation of annual screening with breast magnetic resonance imaging (MRI)
  3. C
    Ovarian cancer screening with transvaginal ultrasonography and serum CA-125
  4. D
    Reassurance and scheduling of biennial screening mammography starting at age 40
  5. E
    Initiation of oral tamoxifen for breast cancer chemoprevention

Cevap

The most appropriate next step is referral for formal genetic counseling and consideration of BRCA mutation testing.
This patient's family history includes male breast cancer and ovarian cancer, which are highly characteristic of a BRCA mutation (particularly BRCA2 for male breast cancer). According to the USPSTF guidelines, women with a family history associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes should be referred for genetic counseling and, if indicated, genetic testing. It is a common misconception that paternal family history is less relevant for breast and ovarian cancer risk; however, these mutations are inherited in an autosomal dominant pattern and can be passed through the paternal line. Genetic counseling must precede the initiation of high-risk screening modalities or chemoprevention.

Adım Adım Çözüm

1
Analyze the patient's family history for high-risk hereditary cancer patterns.
The patient has a father with male breast cancer and a paternal grandmother with ovarian cancer.
Identifying hereditary cancer syndromes is crucial for implementing appropriate high-risk screening and prevention protocols.
2
Apply USPSTF guidelines for BRCA-related cancer risk assessment.
A family history of male breast cancer and ovarian cancer, even on the paternal side, strongly suggests a BRCA1 or BRCA2 mutation.
USPSTF recommends that primary care clinicians assess women with a family history suggestive of BRCA mutations and refer them for formal genetic counseling.
3
Evaluate the distractor options against standard test sequencing principles.
MRI, tamoxifen, and routine mammography at age 40 are inappropriate initial steps. TVUS and CA-125 are explicitly not recommended for ovarian cancer screening.
Proper test sequencing dictates that genetic risk must be formally established via counseling before initiating high-risk imaging or chemopreventive medications.

Anahtar Kavram

Women with a family history indicative of a potential BRCA mutation (including paternal history of breast/ovarian cancer or any male breast cancer) should be referred for formal genetic counseling before initiating high-risk screening or chemoprevention.
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru